Use of a Cloud-connected Remote Blood Pressure Monitoring Program During the Postpartum Period for Hypertensive Women (BP-ME)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Research Nurse
- Phone Number: 803-687-9974
- Email: gwendoline.helin-milgrom@prismahealth.org
Study Locations
-
-
South Carolina
-
Columbia, South Carolina, United States, 29203
- Prisma Health Richland
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Pregnant individuals with hypertensive disorders
- Speak English
- At least 18 years old
- Medicaid coverage
- Between 20 weeks of pregnancy and 2 weeks postpartum
- Postpartum admission at Prisma Health Richland with hypertensive disorder within 2 weeks postpartum
Exclusion Criteria:
- Not planning to deliver at Prisma Health Richland
- Less than 20 weeks of pregnancy
- More than 2 weeks postpartum
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Intervention
Intervention group will receive blood pressure (BP) cuffs.
The BP cuff is connected in a Health Insurance Portability and Accountability Act-compliant fashion to the patient's medical record, allowing for documentation and communication with the nurse and the care team.
Alerts are triggered if a patient has not checked her BP for 3 days or when readings fall outside a specific threshold (high or low BP alerts).
Based on these alerts, the nurse follows up with these patients and reminds them to take a reading.
The nurse will also notify participants with elevated BP values to repeat their BP and will contact the participants by phone to discuss symptoms and antihypertensive medications.
Patients will be managed based on a clinical algorithm for initiation of antihypertensive medications without the need for an outpatient visit if considered appropriate by the clinical provider.
|
The BP cuff is connected in a Health Insurance Portability and Accountability Act-compliant fashion to the patient's medical record, allowing for documentation and communication with the nurse and the care team.
Alerts are triggered if a patient has not checked her BP for 3 days or when readings fall outside a specific threshold (high or low BP alerts).
Based on these alerts, the nurse follows up with these patients and reminds them to take a reading.
The nurse will also notify participants with elevated BP values to repeat their BP and will contact the participants by phone to discuss symptoms and antihypertensive medications.
Patients will be managed based on a clinical algorithm for initiation of antihypertensive medications without the need for an outpatient visit if considered appropriate by the clinical provider.
|
|
Historical or Concurrent controls
Individuals who had hypertensive disorders during pregnancy but who did not receive the BP cuffs will serve as the control group.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood pressure ascertainment
Time Frame: First 6 weeks postpartum
|
BP ascertainment i.e., percent of patients submitting at least one BP value, the average number of unique BP measures per patient during the first six-weeks postpartum, and percent of patients continuing the program beyond 3 weeks postpartum.
|
First 6 weeks postpartum
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent of patients attending an in-person postpartum visit
Time Frame: First 8 weeks postpartum
|
First 8 weeks postpartum
|
|
|
Percent of patients readmitted to the hospital through 12 months postpartum
Time Frame: 12 months postpartum
|
12 months postpartum
|
|
|
Survey assessing patient's acceptability and satisfaction with the BP monitoring program
Time Frame: First 8 weeks postpartum
|
The survey questions will include comfort with the technology and satisfaction with the BP monitoring program.
All survey items will be assessed using a 5-item Likert scale (score of 1-strong disagreement, 3-neutral, 5-strong agreement) and will be administered through the telehealth platform starting on day 35 of the program.
Patients who do not complete the survey will be contacted to complete it by phone or at their postpartum visit.
|
First 8 weeks postpartum
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2085188
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.